Anand Rathi: The Covid-19 Vaccination Race Has Just Begun; India Aptly Placed
BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
Anand Rathi Report
Global cases of Covid-19 continue rising; a vaccine is an essential measure to counter the next wave.
Recent data for three vaccines have raised expectations; an approved one is likely in the next few weeks. Pfizer Ltd. and Moderna have filed applications with the U.S. Food and Drug Administration under the emergency-use authorisation; decisions regarding them could be taken in the next few days.
While most countries are trying to obtain dosages for their people, India has secured over 1.6 billion doses through vaccine manufacturers.
Seven Indian pharma companies have collaborated or are working on an indigenous vaccine.
Click on the attachment to read the full report:
This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the brokerage and do not represent the views of BloombergQuint.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.